TMCnet News
What are Wearables and How are They Impacting Pharma? - Research and MarketsResearch and Markets has announced the addition of the "Wearables are Transforming R&D and Care Delivery" report to their offering. Wearables encompass the growing range of gadgets that can be attached to the body to measure certain physiological parameters. They are rapidly being adopted in healthcare, as part of a broader health IT revolution, with significant consequences for pharma in both the economics and execution of R&D. There are already an estimated 300 trials underway involving wearables, according to National Institutes of Health data reported in late 2015. Wearables' most immediate potential is in chronic diseases. This report addresses the following questions: - What are wearables and how are they impacting pharma? - Who is developing wearables and what partnerships have pharma companies forged as they venture into this new domain? - What are the key drivers and resistors to wearables' use in healthcare? - How has pharma experimented with wearables so far and what are the key takeaways for drug developers? - What impact have wearables had on pharma R&D so far? - How will wearables fit within the pharma business model and where is there most potential to generate return on investment from weaables? Key Topics Covered: 1. What are wearables, and why should pharma care? 2. Wearables makers: pharma partners or competitors? 3. Wearables' early impact in R&D and beyond 4. Drivers and resistors of wearables in healthcare 5. Case studies involve a range of players, devices, and therapy areas 6. Wearables are part of digital health investments What are Wearables, and Why Should Pharma Care? 7. Wellness and medicine: blurring boundaries 8. Enabling patient centricity; lowering costs 9. Bibliography Wearables Makers: Pharma Partners or Competitors? 10. Who is making wearables? 11. Fostering and funding digital health innovation 12. Bibliography Wearables' Early Impact in R&D and Beyond 13. Most wearables trials to date have been feasibility studies 14. Bibliography Drivers and Resistors of Wearables in Healthcare 15. Drivers 16. Resistors 17. Bibliography Wearables Case Studies 18. Wearables are used along the value chain and across stakeholders 19. Biogen-Google (News - Alert): uncovering the course of multiple sclerosis 20. Novartis-Qualcomm: building the foundations for mobile trials 21. Novartis-Microsoft (News - Alert): measuring multiple sclerosis 22. UCB-MC10: improving diagnosis and treatment of Parkinson's disease 23. Johns Hopkins-Apple (News - Alert): using Apple Watch to predict seizures 24. UnitedHealthcare-Qualcomm: paying for steps 25. Medibio-Medtronic: diagnosing depression 26. Google (Verily)-Dexcom: stick-on glucose monitors for diabetes 27. Otsuka-Proteus (News - Alert) Digital Health: digital medicines may improve outcomes but first must pass regulatory muster 28. Bibliography Wearables are Part of Digital Health Investments 29. Unquantified investments 30. Efficacy gains expected 31. Who will pay for wearables in healthcare? 32. The technological future, 33. Bibliography For more information visit http://www.researchandmarkets.com/research/3td84q/wearables_are
View source version on businesswire.com: http://www.businesswire.com/news/home/20160720005698/en/ |